Effects of colchicine on the prevention of AF recurrence after atrial ablation: a systematic review and meta-analysis
Journal of Interventional Cardiac Electrophysiology · 24.02.2024 · 67 (8) · 1951-1958
DOI: 10.1007/s10840-024-01770-6 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Interventional Cardiac Electrophysiology, online erschienen am 24.02.2024. Verfasst von Elísio Bulhões und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medicine Department, Faculty of Higher Education of the Reunida Amazon, Redenção, Pará, Brazil. elisiosantos271@gmail.com. Hauptthemen laut MEDLINE: Colchicine, Atrial Fibrillation, Catheter Ablation, Secondary Prevention. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Catheter ablation has become a widely accepted treatment for atrial fibrillation, but early recurrences remain a challenge, often attributed to inflammatory responses triggered during the procedure. This systematic review and meta-analysis aimed to evaluate the effectiveness of colchicine in preventing short-term AF recurrence post-ablation. METHOD: PubMed, Embase, and Cochrane Library were searched for studies comparing use of colchicine and placebo in patients after AF ablation. Outcomes included AF recurrence, GI side effects, and hospitalization. R program (version 4.3.2) was used for statistical analysis. Heterogeneity was assessed with I2 statistics. RESULTS: Five studies, including 1592 patients, were analyzed. Pooled results revealed no statistically significant decrease in AF recurrence (OR 0.74; 95% CI 0.48-1.12; p = 0.153) and pericarditis rates (OR 0.67; 95% CI 0.26-1.72; p = 0.403) with colchicine use. No significant difference in hospitalization rates was observed between colchicine and placebo groups (OR 1.00; 95% CI 0.63-1.59; p = 0.996). In addition, gastrointestinal side effects were notably higher in the colchicine group (OR 4.84; 95% CI 2.58-9.05; p < 0.001). CONCLUSION: Prophylactic use of colchicine after atrial ablation was not associated with a reduction in AF recurrence and pericarditis rates. In addition, there was no difference in the rate of all-cause hospitalization between the groups, and colchicine use was associated with gastrointestinal adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicine Department, Faculty of Higher Education of the Reunida Amazon, Redenção, Pará, Brazil. elisiosantos271@gmail.com.
- Medicine Department, Federal University of Pernambuco, Recife, Pernambuco, Brazil.
- Medicine Department, Federal University of Piauí, Teresina, Piauí, Brazil.
- Cardiovascular Diseases Department, Mayo Clinic, Rochester, MN, USA.
Zitieren
APA
Bulhões, E., Florêncio de Mesquita, C., Madeira de Sá Pacheco, I., & Karlinski Vizentin, V. (2024). Effects of colchicine on the prevention of AF recurrence after atrial ablation: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology, 67(8), 1951-1958. https://doi.org/10.1007/s10840-024-01770-6
Vancouver
Bulhões E, Florêncio de Mesquita C, Madeira de Sá Pacheco I, Karlinski Vizentin V. Effects of colchicine on the prevention of AF recurrence after atrial ablation: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology. 2024;67(8):1951-1958. doi:10.1007/s10840-024-01770-6
BibTeX
@article{Bulhes2024,
author = {Bulhões, Elísio and Florêncio de Mesquita, Cynthia and Madeira de Sá Pacheco, Isabela and Karlinski Vizentin, Vanessa},
title = {Effects of colchicine on the prevention of AF recurrence after atrial ablation: a systematic review and meta-analysis},
journal = {Journal of Interventional Cardiac Electrophysiology},
year = {2024},
volume = {67},
number = {8},
pages = {1951--1958},
doi = {10.1007/s10840-024-01770-6}
}
EUVIMED